MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

At the Longhorn Vaccines and Diagnostics Presents Compelling Data on the LHNVD-303 Vaccine for Sepsis Linked to Bacterial Infections

28 Apr 2025

Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools...

Spyre Therapeutics Announces Inducement Award Grants

IKA introduces new accessories for the HABITAT research bioreactor.

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

Datar Cancer Genetics will provide groundbreaking video-enhanced results of in-vitro chemotherapy effectiveness tests for cancer patients

LEVEL Relief Protab Reduced Everyday Aches and Pain in an Independent 29-Day Study

By LEVEL
LEVEL
22 Sep 2026

FDA Updates WINREVAIR™ Label with HYPERION Phase 3 Trial Data in Adults Newly Diagnosed with PAH

By Merck & Co., Inc.
Merck & Co., Inc.
22 Sep 2026

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

By Padagis
Padagis
21 Sep 2026

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

By StimCardio’s
StimCardio’s
21 Sep 2026

Bruker Receives Order for High-Field NMR Systems to Support a Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley.

By Bruker Corporation
Bruker Corporation
21 Sep 2026

Scitara Appoints Mike Tarselli as Chief Strategy Officer to Drive Growth in Lab Intelligence

By Scitara
Scitara
21 Sep 2026

Most Popular

BioMarin to Present Data Showcasing VOXZOGO® (vosoritide)'s Impact on Bone Health and Quality of Life in Achondroplasia

By BioMarin Pharmaceutical Inc.

Jun 17
VCU Collaboration Launched by Galmed Pharmaceuticals to Address Drug Resistance in GI Cancers

By Galmed Pharmaceuticals Ltd.

Apr 18
MediPharm Labs launches a new nighttime inhaler, expanding its leading CBN oil portfolio

By MediPharm Labs Corp.

Jul 30

September 2026

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

At the Longhorn Vaccines and Diagnostics Presents Compelling Data on the LHNVD-303 Vaccine for Sepsis Linked to Bacterial Infections

Spyre Therapeutics Announces Inducement Award Grants

IKA introduces new accessories for the HABITAT research bioreactor.

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

Datar Cancer Genetics will provide groundbreaking video-enhanced results of in-vitro chemotherapy effectiveness tests for cancer patients

LEVEL Relief Protab Reduced Everyday Aches and Pain in an Independent 29-Day Study

FDA Updates WINREVAIR™ Label with HYPERION Phase 3 Trial Data in Adults Newly Diagnosed with PAH

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

Bruker Receives Order for High-Field NMR Systems to Support a Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley.

Scitara Appoints Mike Tarselli as Chief Strategy Officer to Drive Growth in Lab Intelligence

Most Popular

BioMarin to Present Data Showcasing VOXZOGO® (vosoritide)'s Impact on Bone Health and Quality of Life in Achondroplasia

VCU Collaboration Launched by Galmed Pharmaceuticals to Address Drug Resistance in GI Cancers

MediPharm Labs launches a new nighttime inhaler, expanding its leading CBN oil portfolio

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter